Omnicare To Pay $50M To Settle DEA's Rx Misconduct Claims
Nursing-home pharmacy firm Omnicare Inc. said Friday it has been fined $50 million for doling out controlled substances without proper prescriptions, misconduct the company suggested resulted from a murky understanding of...To view the full article, register now.
Already a subscriber? Click here to view full article